Essex Bio-Technology - Stock

Essex Bio-Technology ROE 2024

Essex Bio-Technology ROE

0.14

Ticker

1061.HK

ISIN

KYG312371035

WKN

693609

In 2024, Essex Bio-Technology's return on equity (ROE) was 0.14, a 9.9% increase from the 0.13 ROE in the previous year.

Essex Bio-Technology Aktienanalyse

What does Essex Bio-Technology do?

Essex Bio-Technology Ltd is a biotechnology company that was founded in Essex, England in 1999. The company specializes in the research and development of innovative products in the healthcare sector, with a focus on the development of vaccines for globally prevalent diseases. Over the years, Essex Bio-Technology Ltd has evolved into a global company operating in Europe, Asia, Africa, and North America. It has offices in the UK, Canada, and China. The company is dedicated to improving the health and well-being of people worldwide, utilizing cutting-edge technology and scientific innovations. Its business model is based on the research, development, and marketing of biotechnology products for the pharmaceutical industry. One of the key areas of focus for Essex Bio-Technology Ltd is the discovery and development of vaccines. The company has made significant progress in particular in the development of vaccines for influenza and tuberculosis. It has also collaborated with other companies in the development of a vaccine for COVID-19. In addition to vaccines, Essex Bio-Technology Ltd has also developed products for medical diagnostics and cancer immunotherapy. These products are used in medical practice and have proven to be extremely successful. Overall, Essex Bio-Technology Ltd has developed an impressive range of products that cover important areas of healthcare. The products are of the highest quality and meet the highest standards in the biotechnology industry. In recent years, the company has established a strong partnership with the pharmaceutical industry. It has conducted collaborative research projects with some of the largest companies in the field to develop new biotechnology products. It has also played a central role in collaboration with governments and non-profit organizations worldwide to ensure that critical medical needs are met. Essex Bio-Technology Ltd stands for the highest quality standards and a commitment to improving healthcare. The company is a leader in biotechnological research and development and has made a name for itself in the pharmaceutical industry. It is a company to be proud of and one that is at the forefront of the journey towards better healthcare for all worldwide. Essex Bio-Technology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Essex Bio-Technology's Return on Equity (ROE)

Essex Bio-Technology's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Essex Bio-Technology's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Essex Bio-Technology's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Essex Bio-Technology’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Essex Bio-Technology stock

What is the ROE (Return on Equity) of Essex Bio-Technology this year?

The ROE of Essex Bio-Technology this year is 0.14 undefined.

How has the Return on Equity (ROE) of Essex Bio-Technology developed compared to the previous year?

The ROE of Essex Bio-Technology has increased by 9.9% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Essex Bio-Technology?

A high ROE indicates that Essex Bio-Technology generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Essex Bio-Technology?

A low ROE can indicate that Essex Bio-Technology is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Essex Bio-Technology affect the company?

A change in ROE (Return on Equity) of Essex Bio-Technology can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Essex Bio-Technology?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Essex Bio-Technology?

Some factors that can influence Essex Bio-Technology's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Essex Bio-Technology pay?

Over the past 12 months, Essex Bio-Technology paid a dividend of 0.07 HKD . This corresponds to a dividend yield of about 2.9 %. For the coming 12 months, Essex Bio-Technology is expected to pay a dividend of 0.08 HKD.

What is the dividend yield of Essex Bio-Technology?

The current dividend yield of Essex Bio-Technology is 2.9 %.

When does Essex Bio-Technology pay dividends?

Essex Bio-Technology pays a quarterly dividend. This is distributed in the months of October, July, September, June.

How secure is the dividend of Essex Bio-Technology?

Essex Bio-Technology paid dividends every year for the past 0 years.

What is the dividend of Essex Bio-Technology?

For the upcoming 12 months, dividends amounting to 0.08 HKD are expected. This corresponds to a dividend yield of 3.2 %.

In which sector is Essex Bio-Technology located?

Essex Bio-Technology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Essex Bio-Technology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Essex Bio-Technology from 6/17/2024 amounting to 0.045 HKD, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.

When did Essex Bio-Technology pay the last dividend?

The last dividend was paid out on 6/17/2024.

What was the dividend of Essex Bio-Technology in the year 2023?

In the year 2023, Essex Bio-Technology distributed 0.095 HKD as dividends.

In which currency does Essex Bio-Technology pay out the dividend?

The dividends of Essex Bio-Technology are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Essex Bio-Technology

Our stock analysis for Essex Bio-Technology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Essex Bio-Technology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.